RE: Thailand28 Mar 2021 13:41
It was mentioned in the half year's report:
"We have obtained regulatory approval in Europe, in South Africa and Thailand.
Performance in external trials (covering over 200 samples across four sites) has been very good, and we remain confident in the performance of the product. The Company has implemented a regular review process of emerging viral variants, and to date the reported strains have not adversely affected our assay design."